- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
TOLLIP Antibody / Toll-Interacting Protein Polyclonal Antibody targets Toll-interacting protein (TOLLIP), an intracellular adaptor protein involved in inflammatory signaling, endosomal trafficking, and the regulation of protein degradation. TOLLIP participates in several cellular processes that connect innate immune receptor activation with membrane trafficking and protein homeostasis. Its ability to interact with signaling proteins, phospholipids, and ubiquitinated substrates allows it to coordinate distinct pathways involved in maintaining cellular responses to environmental stimuli.
TOLLIP was initially characterized through its association with the interleukin-1 receptor signaling pathway. It interacts with components of the IL-1 receptor complex and interleukin-1 receptor-associated kinase 1 (IRAK1), contributing to the regulation of downstream inflammatory responses. TOLLIP also modulates signaling associated with Toll-like receptors, including pathways that activate NF-kappaB and influence the production of inflammatory mediators. Depending on cellular context, these interactions can help limit excessive receptor signaling and contribute to the maintenance of immune homeostasis.
The protein contains several functionally important regions, including a C2 domain and a C-terminal CUE domain. The C2 domain participates in phospholipid interactions and contributes to membrane association, while the CUE domain recognizes ubiquitin and ubiquitinated proteins. These structural features enable TOLLIP to function at the intersection of intracellular signaling and membrane trafficking. Its interactions with endosomal components are particularly important for regulating the localization and processing of selected protein cargo.
TOLLIP also participates in endosomal sorting and autophagy-related processes. Through interactions with ubiquitinated substrates and trafficking machinery, it contributes to the movement of proteins between intracellular compartments and their delivery to degradative pathways. These functions connect TOLLIP with broader mechanisms of proteostasis, including the cellular response to protein accumulation and changes in lysosomal activity.
Altered TOLLIP expression or function has been investigated in inflammatory disorders, pulmonary disease, and conditions involving disrupted innate immune regulation. Genetic variation affecting TOLLIP has also been associated with differences in susceptibility to certain inflammatory and infectious diseases. The biological consequences of these changes depend on the signaling pathways and cellular environments involved.
TOLLIP Antibody supports investigations into the molecular mechanisms connecting inflammatory signaling, ubiquitin recognition, endosomal trafficking, and intracellular protein homeostasis.
Explore additional antibodies targeting intracellular signaling proteins, inflammatory regulators, and adaptor molecules in our Signal Transduction Antibodies collection.
Optimal dilution of the TOLLIP Antibody / Toll-Interacting Protein Polyclonal Antibody should be determined by the researcher.
E. coli-derived recombinant human protein (amino acids M1-P274) was used as the immunogen for the Toll-interacting protein antibody.
After reconstitution, the Toll-interacting protein antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Toll-interacting protein antibody, Toll-like receptor interacting protein antibody, TOLLIP adaptor protein antibody, IL-1 receptor-associated adaptor protein antibody, Toll pathway interacting protein antibody, TOLLIP ubiquitin-binding protein antibody, TOLLIP CUE domain protein antibody, TOLLIP C2 domain protein antibody, Toll-interacting protein 1 antibody, TOLLIP signaling adaptor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.